Skip to main content

Peer Review reports

From: Integrated analysis identifies GABRB3 as a biomarker in prostate cancer

Original Submission
3 Oct 2023 Submitted Original manuscript
12 Nov 2023 Reviewed Reviewer Report
14 Dec 2023 Reviewed Reviewer Report - Shiv Verma
4 Jan 2024 Author responded Author comments - Bo-Ying Bao
Resubmission - Version 2
4 Jan 2024 Submitted Manuscript version 2
Publishing
23 Jan 2024 Editorially accepted
29 Jan 2024 Article published 10.1186/s12920-024-01816-8

You can find further information about peer review here.

Back to article page